Cero Therapeutics
CERo Therapeutics, Inc. is a new cellular immunotherapy company. We have created a hybrid platform that integrates innate and adaptive programs to eliminate disease.
View Top Employees for Cero Therapeutics
|
Website | cero.bio |
|
Industry | Biotechnology |
|
Location | South San Francisco, California, United States |
|
Employees | 15 |
|
Founded | 2017 |
|
HQ | 329 Oyster Point Blvd, 3rd Floor South |
|
Funding | 41,399,999 USD |
|
Competitors | Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences, |
|
|
Website | cero.bio |
|
|
Industry | Biotechnology |
|
|
Location | South San Francisco, California, United States |
|
|
Employees | 15 |
|
|
Founded | 2017 |
|
linkedin.com/company/cero-therapeutics | |
|
|
HQ | 329 Oyster Point Blvd, 3rd Floor South |
|
|
Funding | 41,399,999 USD |
Email Patterns for Cero Therapeutics
Top Competitors for Cero Therapeutics
Cero Therapeutics Questions
Where are Cero Therapeutics's headquarters?
Cero Therapeutics's headquarters are in 329 Oyster Point Blvd, 3rd Floor South
What is Cero Therapeutics's official website?
Cero Therapeutics's website is cero.bio
How many employees are working in Cero Therapeutics right now?
Cero Therapeutics has
15 employees.
View the Email and Phone Numbers for all 15 working at Cero Therapeutics.
What is Cero Therapeutics's industry?
Cero Therapeutics's industry is
Biotechnology
Who are Cero Therapeutics's top competitors?
Cero Therapeutics's top competitors are
Roche
,
Agilent Technologies
,
Amgen
,
Genentech
,
Eurofins
,
Gilead Sciences
What are Cero Therapeutics's categories?
Cero Therapeutics's categories are Biotechnology, Therapeutics
What is Cero Therapeutics's location?
Cero Therapeutics's location is
South San Francisco, California, United States
When was Cero Therapeutics's founded?
Cero Therapeutics's founding year is 2017
What is Cero Therapeutics's funding?
Cero Therapeutics's funding is 41,399,999 USD
What is Cero Therapeutics's current status?
Cero Therapeutics's current status is operating
Top Cero Therapeutics Employees
Senior Director, Vector Development
jared.clever@immunoscience.com
+1925-463-1500
Senior Research Associate
+1415-601-5861
Senior Scientist
amanda.marchiando@nyu.edu
+1212-677-5348
Senior Research Associate
will_roscoe@hotmail.com
+1415-215-2058
Principal Scientist
brandon.cieniewicz@gmail.com
+1631-605-9936
Team Lead
yanqu1012@gmail.com
+1212-573-3115
Senior Vice President, Head Of Translational Medicine
jrossi@kitepharma.com
+1310-824-9999
